Product Details for ANDA 210575
ATAZANAVIR SULFATE (ATAZANAVIR SULFATE)
EQ 150MG BASE
Marketing Status: Discontinued
EQ 200MG BASE
Marketing Status: Discontinued
EQ 300MG BASE
Marketing Status: Discontinued
EQ 150MG BASE
Marketing Status: Discontinued
Active Ingredient: ATAZANAVIR SULFATE
Proprietary Name: ATAZANAVIR SULFATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A210575
Product Number: 001
Approval Date: Jun 4, 2020
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ATAZANAVIR SULFATE (ATAZANAVIR SULFATE)
Proprietary Name: ATAZANAVIR SULFATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A210575
Product Number: 001
Approval Date: Jun 4, 2020
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 200MG BASE
Marketing Status: Discontinued
Active Ingredient: ATAZANAVIR SULFATE
Proprietary Name: ATAZANAVIR SULFATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 200MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A210575
Product Number: 002
Approval Date: Jun 4, 2020
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ATAZANAVIR SULFATE (ATAZANAVIR SULFATE)
Proprietary Name: ATAZANAVIR SULFATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 200MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A210575
Product Number: 002
Approval Date: Jun 4, 2020
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 300MG BASE
Marketing Status: Discontinued
Active Ingredient: ATAZANAVIR SULFATE
Proprietary Name: ATAZANAVIR SULFATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 300MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A210575
Product Number: 003
Approval Date: Jun 4, 2020
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: ATAZANAVIR SULFATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 300MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A210575
Product Number: 003
Approval Date: Jun 4, 2020
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information